localized transitional cell cancer of the renal pelvis and ureter
Showing 26 - 50 of >10,000
ResiduAl Cancer With Liquid Biopsy Evaluation
Recruiting
- Bladder Carcinoma
- +14 more
- Guardant Reveal
-
Redwood City, CaliforniaRedwood City
Sep 7, 2022
Urothelial Cancer of Renal Pelvis, Urothelial Carcinoma Ureter Trial in Dallas (sterile water irrigation, Gemcitabine)
Recruiting
- Urothelial Cancer of Renal Pelvis
- Urothelial Carcinoma Ureter
- sterile water irrigation
- Gemcitabine
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Nov 30, 2021
Urological Malignancies, Prostate Cancer, Renal Cell Cancer Trial in Seoul
Recruiting
- Urological Malignancies
- +4 more
-
Seoul, Korea, Republic ofYonsei Severance Hospital
Jan 30, 2023
Carcinoma, Transitional Cell Trial in San Francisco (Atezolizumab)
Active, not recruiting
- Carcinoma, Transitional Cell
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 24, 2022
Carcinoma, Renal Cell Trial in Pittsburgh (Autologous alpha-DC1/TBVA vaccine, Cabozantinib)
Not yet recruiting
- Carcinoma, Renal Cell
- Autologous alpha-DC1/TBVA vaccine
- Cabozantinib
-
Pittsburgh, PennsylvaniaUPMC Department of Urology
Jan 5, 2023
Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)
Recruiting
- Kidney Cancer
- +11 more
- 13C-Glucose
- +4 more
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Dec 1, 2022
Renal Cell Carcinoma, Urothelial Carcinoma, Cervical Cancer Trial in Shanghai (SHR-1210, Famitinib)
Recruiting
- Renal Cell Carcinoma
- +4 more
- SHR-1210
- Famitinib
-
Shanghai, Shanghai, ChinaHuadong Hospital Affiliated to Fudan University
Jun 30, 2022
A Genotype-Phenotype Urothelial Cancer Registry
Recruiting
- Urothelial Cancer
- +3 more
- saliva sample and questionaire
- saliva sample, questionaire
-
Basking Ridge, New Jersey
- +3 more
Jun 2, 2022
Renal Cell Carcinoma, Adrenal Tumor, Nonfunctioning Kidney Trial (telesurgery by domestic surgical robot)
Not yet recruiting
- Renal Cell Carcinoma
- +13 more
- telesurgery by domestic surgical robot
- (no location specified)
Feb 12, 2023
High Grade Urothelial Carcinoma, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore (Enfortumab
Not yet recruiting
- High Grade Urothelial Carcinoma
- +2 more
- Enfortumab vedotin
- Pembrolizumab
-
Washington, District of Columbia
- +1 more
Jan 5, 2023
Metastatic Solid Tumors, NSCLC, Melanoma Trial in United States (INBRX-105 - PDL1x41BB antibody, Pembrolizumab)
Recruiting
- Metastatic Solid Tumors
- +7 more
- INBRX-105 - PDL1x41BB antibody
- Pembrolizumab
-
Scottsdale, Arizona
- +12 more
Jan 26, 2023
Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in
Completed
- Distal Urethral Cancer
- +10 more
- Gemcitabine hydrochloride
- +3 more
-
Springfield, Missouri
- +1 more
Sep 17, 2020
Advanced Bladder Urothelial Carcinoma, Advanced Renal Pelvis Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma Trial in
Recruiting
- Advanced Bladder Urothelial Carcinoma
- +17 more
- Avelumab
- +3 more
-
Auburn, California
- +111 more
Aug 17, 2022
Bladder Squamous Cell Carcinoma, Locally Advanced Bladder Carcinoma, Malignant Renal Pelvis Tumor Trial in Atlanta (procedure,
Not yet recruiting
- Bladder Squamous Cell Carcinoma
- +10 more
- Biospecimen Collection
- +5 more
-
Atlanta, Georgia
- +3 more
Feb 20, 2023
Infiltrating Bladder Urothelial Carcinoma, Recurrent Bladder Carcinoma, Stage I Prostate Cancer Trial in Los Angeles (other,
Terminated
- Infiltrating Bladder Urothelial Carcinoma
- +9 more
- Cytology Specimen Collection Procedure
- +4 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 15, 2021
Urinary Bladder Cancer Trial in München, Ulm, Würzburg (drug, radiation, procedure)
Active, not recruiting
- Urinary Bladder Cancer
- Nivolumab
- +2 more
-
München, Germany
- +2 more
Oct 19, 2022
Long Non-coding MFI2-AS1 RNA in Localized Clear Cell Kidney
Recruiting
- Kidney Cancer
- Surgical intervention
-
Strasbourg, FranceLes Hôpitaux Universitaires de Strasbourg
Dec 13, 2021
Recurrent Bladder Urothelial Carcinoma, Recurrent Renal Pelvis Urothelial Carcinoma, Recurrent Ureter Urothelial Carcinoma Trial
Completed
- Recurrent Bladder Urothelial Carcinoma
- +19 more
- Erlotinib Hydrochloride
-
Houston, TexasM D Anderson Cancer Center
Aug 21, 2020
Carcinoma, Transitional Cell, Urinary Bladder Tumors, Urologic Tumors Trial in Worldwide (enfortumab vedotin (EV),
Active, not recruiting
- Carcinoma, Transitional Cell
- +6 more
- enfortumab vedotin (EV)
- +4 more
-
Anchorage, Alaska
- +105 more
Dec 19, 2022
Renal Cell Carcinoma, Urothelial Carcinoma Trial in Oklahoma City (Bone Marrow Aspirate)
Terminated
- Renal Cell Carcinoma
- Urothelial Carcinoma
- Bone Marrow Aspirate
-
Oklahoma City, OklahomaStephenson Cancer Center
Jul 8, 2021
Localized Renal Pelvis and Ureter Urothelial Carcinoma, Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal
Active, not recruiting
- Localized Renal Pelvis and Ureter Urothelial Carcinoma
- +10 more
- Biospecimen Collection
- +9 more
-
Birmingham, Alabama
- +922 more
Jan 28, 2023
Metastatic Bladder Urothelial Carcinoma, Metastatic Renal Pelvis and Ureter Urothelial Carcinoma, Metastatic Ureter Urothelial
Active, not recruiting
- Metastatic Bladder Urothelial Carcinoma
- +3 more
- Berzosertib
- +2 more
-
Phoenix, Arizona
- +38 more
Jul 13, 2022
Renal Cell Carcinoma (RCC), Urothelial Carcinoma, Primary Peritoneal Cancer Trial in Canada, United States (DSP-7888 Dosing
Completed
- Renal Cell Carcinoma (RCC)
- +5 more
- DSP-7888 Dosing Emulsion
- +2 more
-
Tucson, Arizona
- +18 more
Dec 6, 2022
Bladder Small Cell Neuroendocrine Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Bladder Urothelial Carcinoma
Recruiting
- Bladder Small Cell Neuroendocrine Carcinoma
- +16 more
- Carboplatin
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Mar 23, 2022